Stephane Peluso

age ~54

from Natick, MA

Get Report
Also known as:
  • Stephanie Peluso
Phone and address:
38 Algonquian Dr, Natick, MA 01760
Related to:
Connected to:

Stephane Peluso Phones & Addresses

  • 38 Algonquian Dr, Natick, MA 01760
  • Brookline, MA
  • 97 Josephine Ave, Somerville, MA 02144 • 6176660697
  • 183 College Ave, Somerville, MA 02144 • 6176666856
  • 2386 Massachusetts Ave, Cambridge, MA 02140

Us Patents

  • Cyclopamine Analogs

    view source
  • US Patent:
    7812164, Oct 12, 2010
  • Filed:
    Dec 27, 2007
  • Appl. No.:
    11/965688
  • Inventors:
    Brian Austad - Tewksbury MA, US
    Mark L. Behnke - Somerville MA, US
    Alfredo C. Castro - Winchester MA, US
    Michael J. Grogan - Winchester MA, US
    Andre Lescarbeau - Somerville MA, US
    Stephane Peluso - Somerville MA, US
    Martin Tremblay - Melrose MA, US
  • Assignee:
    Infinity Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C07D 401/00
    C07D 515/02
  • US Classification:
    546 17, 546115, 549331, 549345
  • Abstract:
    The invention provides novel derivatives of cyclopamine having the following formula:.

  • Compounds And Methods For Inhibiting The Interaction Of Bcl Proteins With Binding Partners

    view source
  • US Patent:
    7928244, Apr 19, 2011
  • Filed:
    Aug 21, 2007
  • Appl. No.:
    11/842581
  • Inventors:
    Alfredo C. Castro - Winchester MA, US
    Kristopher M. Depew - Acton MA, US
    Michael J. Grogan - Winchester MA, US
    Charles W. Johannes - Newbury MA, US
    Edward B. Holson - Newton Highlands MA, US
    Brian T. Hopkins - Newton MA, US
    Gregg F. Keaney - Belmont MA, US
    Nii O. Koney - Brighton MA, US
    Tao Liu - Ashland MA, US
    David A. Mann - Swampscott MA, US
    Marta Nevalainen - Quincy MA, US
    Stephane Peluso - Somerville MA, US
    Lawrence B. Perez - Hopkinton MA, US
    Daniel A. Snyder - Somerville MA, US
    Thomas T. Tibbitts - Westford MA, US
  • Assignee:
    Infinity Discovery, Inc. - Cambridge MA
  • International Classification:
    C07D 261/02
    A61K 31/42
  • US Classification:
    548240, 514378
  • Abstract:
    The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.

  • Substituted Pyrrolo[2,3-D]Pyrimidines As Inhibitors Of E1 Activating Enzymes

    view source
  • US Patent:
    7951810, May 31, 2011
  • Filed:
    Feb 2, 2006
  • Appl. No.:
    11/346469
  • Inventors:
    Stephen Critchley - Braintree MA, US
    Thomas G. Gant - Carlsbad CA, US
    Steven P. Langston - North Andover MA, US
    Edward J. Olhava - Brookline MA, US
    Stephane Peluso - Somerville MA, US
  • Assignee:
    Millennium Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C07D 487/04
    A61K 31/519
    A61P 35/00
    A61P 25/28
    A61P 29/00
  • US Classification:
    5142651, 544280
  • Abstract:
    This invention relates to compounds of formula (I-A).

  • Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes

    view source
  • US Patent:
    8008307, Aug 30, 2011
  • Filed:
    Aug 6, 2007
  • Appl. No.:
    11/890338
  • Inventors:
    Christopher F. Claiborne - Cambridge MA, US
    Stephen Critchley - Braintree MA, US
    Courtney Cullis - Bedford MA, US
    Steven P. Langston - North Andover MA, US
    Hirotake Mizutani - Cambridge MA, US
    Edward J. Olhava - Cambridge MA, US
    Stephane Peluso - Somerville MA, US
    Irache Visiers - Arlington MA, US
    Stepan Vyskocil - Watertown MA, US
    Gabriel S. Weatherhead - Salem MA, US
  • Assignee:
    Millennium Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C07D 239/48
    A61K 31/505
  • US Classification:
    514256, 5142651, 514269, 514275, 544280, 544319, 544323, 544327
  • Abstract:
    This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.

  • Compounds And Methods For Inhibiting The Interaction Of Bcl Proteins With Binding Partners

    view source
  • US Patent:
    8178690, May 15, 2012
  • Filed:
    Apr 19, 2011
  • Appl. No.:
    13/089530
  • Inventors:
    Alfredo C. Castro - Winchester MA, US
    Kristopher M. Depew - Acton MA, US
    Michael J. Grogan - Winchester MA, US
    Charles W. Johannes - Newbury MA, US
    Edward B. Holson - Newton Highlands MA, US
    Brian T. Hopkins - Newton MA, US
    Gregg F. Keaney - Belmont MA, US
    Nii O. Koney - New York NY, US
    Tao Liu - Ashland MA, US
    David A. Mann - Madison WI, US
    Marta Nevalainen - Quincy MA, US
    Stephane Peluso - Somerville MA, US
    Lawrence Blas Perez - Hopkinton MA, US
    Daniel A. Snyder - Somerville MA, US
    Thomas T. Tibbitts - Westford MA, US
  • Assignee:
    Infinity Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    C07D 261/02
    A61K 31/42
  • US Classification:
    548240, 514378
  • Abstract:
    The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.

  • Compounds And Methods For Inhibiting The Interaction Of Bcl Proteins With Binding Partners

    view source
  • US Patent:
    8304428, Nov 6, 2012
  • Filed:
    Apr 2, 2010
  • Appl. No.:
    12/753319
  • Inventors:
    Alfredo C. Castro - Winchester MA, US
    Michael J. Grogan - Winchester MA, US
    Edward B. Holson - Newton Highlands MA, US
    Brian T. Hopkins - Newton MA, US
    Nii O. Koney - New York NY, US
    Stephane Peluso - Somerville MA, US
    Daniel A. Snyder - Somerville MA, US
  • Assignee:
    Infinity Discovery, Inc. - Cambridge MA
  • International Classification:
    A61K 31/445
  • US Classification:
    514315, 514365, 514423
  • Abstract:
    The present invention relates to heterocyclic compounds that bind to Bcl proteins and inhibit Bcl function, compositions comprising such compounds, and methods for treating and modulating disorders associated with hyperproliferation, such as cancer.

  • Triazoles As Inhibitors Of Fatty Acid Synthase

    view source
  • US Patent:
    8450350, May 28, 2013
  • Filed:
    May 5, 2011
  • Appl. No.:
    13/101970
  • Inventors:
    Adilah Bahadoor - Cambridge MA, US
    Alfredo C. Castro - Winchester MA, US
    Lawrence K. Chan - Brookline MA, US
    Gregg F. Keaney - Lexington MA, US
    Marta Nevalainen - Weymouth MA, US
    Vesa Nevalainen - Weymouth MA, US
    Stephane Peluso - Brookline MA, US
    Thomas T. Tibbitts - Westford MA, US
  • Assignee:
    Infinity Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    A61K 31/41
    A61K 31/4192
    C07D 249/00
    C07D 249/06
  • US Classification:
    514359, 548255
  • Abstract:
    Provided herein are triazole FASN inhibitors of the formula (I):Also provided herein are pharmaceutical compositions of the compounds provided herein as well as methods of their use for the treatment of various disorders such as hyperproliferative disorders, inflammatory disorders, obesity-related disorders and microbial infections.

  • Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes

    view source
  • US Patent:
    8481550, Jul 9, 2013
  • Filed:
    Aug 24, 2011
  • Appl. No.:
    13/216352
  • Inventors:
    Christopher F. Claiborne - Cambridge MA, US
    Stephen Critchley - Braintree MA, US
    Courtney A. Cullis - Bedford MA, US
    Steven P. Langston - North Andover MA, US
    Hirotake Mizutani - Cambridge MA, US
    Edward J. Olhava - Newton MA, US
    Stephane Peluso - Somerville MA, US
    Irache Visiers - Arlington MA, US
    Stepan Vyskocil - Arlington MA, US
    Gabriel S. Weatherhead - Tewksbury MA, US
  • Assignee:
    Millennium Pharmaceuticals, Inc. - Cambridge MA
  • International Classification:
    A61K 31/505
    C07D 239/48
  • US Classification:
    514256, 5142651, 514269, 514275, 544280, 544319, 544323, 544327
  • Abstract:
    This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.

Youtube

Dana cover-Rockstar Rebeldes

Dana cover-Rockstar Rebeldes

Ficou lindoo.

  • Category:
    People & Blogs
  • Uploaded:
    28 Aug, 2012
  • Duration:
    3m 54s

Facebook

Stephane Peluso Photo 1

Stephane Peluso

view source
Stephane Peluso Photo 2

Stephane Peluso s

view source
Get Report for Stephane Peluso from Natick, MA, age ~54
Control profile